Status:
NOT_YET_RECRUITING
FRED Retrospective Study of Intracranial Aneurysms Treatment
Lead Sponsor:
Microvention-Terumo, Inc.
Conditions:
Intracranial Aneurysm
Eligibility:
All Genders
18-90 years
Brief Summary
To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market environment
Detailed Description
Study Objective: To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market. Study Design: Post-...
Eligibility Criteria
Inclusion
- People in China mainland who have been treated with FRED. The patients for whom clinical data are available
Exclusion
- Patients who met the inclusion criteria at all time points were required to be included in the study. Therefore, no specific exclusion criteria were set.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 6 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06982781
Start Date
May 1 2025
End Date
May 6 2027
Last Update
May 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.